Evidence map›Paper›PMID 24367546›Full record

ArticlePloS one2013

Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination.

John A Painter, Edward A Graviss, Hoang Hoa Hai, Duong Thi Cam Nhung, Tran Thi Thanh Nga, Ngan P Ha, Kirsten Wall, Le Thien Huong Loan, Matt Parker, Lilia Manangan and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 3 countries.

John A PainterNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Edward A GravissThe Methodist Hospital Research Institute, Houston, Texas, United States of America.
Hoang Hoa HaiCho Ray Hospital, Visa Medical Unit, Ho Chi Minh City, Vietnam.
Duong Thi Cam NhungCho Ray Hospital, Visa Medical Unit, Ho Chi Minh City, Vietnam.
Tran Thi Thanh NgaCho Ray Hospital, Visa Medical Unit, Ho Chi Minh City, Vietnam.
Ngan P HaThe Methodist Hospital Research Institute, Houston, Texas, United States of America.
Kirsten WallDenver Health and Hospital Authority, Denver, Colorado, United States of America.
Le Thien Huong LoanCho Ray Hospital, Visa Medical Unit, Ho Chi Minh City, Vietnam.
Matt ParkerDenver Health and Hospital Authority, Denver, Colorado, United States of America.
Lilia MananganNational Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Rick O'BrienFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Susan A MaloneyCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
R M HoekstraBiostatistics and Information Management Office, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Randall RevesDenver Health and Hospital Authority, Denver, Colorado, United States of America.
Cho Ray Hospital · VNCenters for Disease Control and Prevention · USCenter for Global Health · USDenver Health Medical Center · USFoundation for Innovative New Diagnostics · CHHealth and Hospital Corporation · USHouston Methodist · USMethodist Hospital · USUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleEach year 1 million persons acquire permanent U.S. residency visas after tuberculosis (TB) screening. Most applicants undergo a 2-stage screening with tuberculin skin test (TST) followed by CXR only if TST-positive at > 5 mm. Due to cross reaction with bacillus Calmette-Guérin (BCG), TST may yield false positive results in BCG-vaccinated persons. Interferon gamma release assays exclude antigens found in BCG. In Vietnam, like most high TB-prevalence countries, there is universal BCG vaccination at birth.

objectives1. Compare the sensitivity of QuantiFERON-TB Gold In-Tube Assay (QFT) and TST for culture-positive pulmonary TB. 2. Compare the age-specific and overall prevalence of positive TST and QFT among applicants with normal and abnormal CXR.

methodsWe obtained TST and QFT results on 996 applicants with abnormal CXR, of whom 132 had TB, and 479 with normal CXR.

resultsThe sensitivity for tuberculosis was 86.4% for QFT; 89.4%, 81.1%, and 52.3% for TST at 5, 10, and 15 mm. The estimated prevalence of positive results at age 15-19 years was 22% and 42% for QFT and TST at 10 mm, respectively. The prevalence increased thereafter by 0.7% year of age for TST and 2.1% for QFT, the latter being more consistent with the increase in TB among applicants.

conclusionsDuring 2-stage screening, QFT is as sensitive as TST in detecting TB with fewer requiring CXR and being diagnosed with LTBI. These data support the use of QFT over TST in this population.

Indexed as

AdolescentAdultBCG VaccineEmigrants and ImmigrantsFemaleHumansMaleSensitivity and SpecificitySkin TestsTuberculosisYoung AdultBCG Vaccine

Identifiers

PMID24367546
PMCPMC3868593
OpenAlexW2067001430

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.